Cargando…

Technology Development Through Pooling ARV Drug Patents: A Vision from China

Unaffordable prices still bar the end-users in China from accessing ARV drugs. Patent protection of ARV drugs has dramatically limited the availability of these lifesaving drugs to AIDS patients in China. The way Chinese government can go to breakthrough the ARV drug patents are suggested as: Make m...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Li, Lu, Hongzhou
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831193/
https://www.ncbi.nlm.nih.gov/pubmed/20224635
http://dx.doi.org/10.2174/1874613601004020054
_version_ 1782178223397797888
author Liu, Li
Lu, Hongzhou
author_facet Liu, Li
Lu, Hongzhou
author_sort Liu, Li
collection PubMed
description Unaffordable prices still bar the end-users in China from accessing ARV drugs. Patent protection of ARV drugs has dramatically limited the availability of these lifesaving drugs to AIDS patients in China. The way Chinese government can go to breakthrough the ARV drug patents are suggested as: Make more generic drugs available through compulsory licensing, impartment from other countries or building ARVs plants by partnerships between governments or generic drug companies. Do a thorough and detailed research on the patent application of ARV drugs to find out the loophole. Try patent pool to make AIDS medicines more affordable and appropriate for patients.
format Text
id pubmed-2831193
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-28311932010-03-11 Technology Development Through Pooling ARV Drug Patents: A Vision from China Liu, Li Lu, Hongzhou Open AIDS J Article Unaffordable prices still bar the end-users in China from accessing ARV drugs. Patent protection of ARV drugs has dramatically limited the availability of these lifesaving drugs to AIDS patients in China. The way Chinese government can go to breakthrough the ARV drug patents are suggested as: Make more generic drugs available through compulsory licensing, impartment from other countries or building ARVs plants by partnerships between governments or generic drug companies. Do a thorough and detailed research on the patent application of ARV drugs to find out the loophole. Try patent pool to make AIDS medicines more affordable and appropriate for patients. Bentham Open 2010-01-19 /pmc/articles/PMC2831193/ /pubmed/20224635 http://dx.doi.org/10.2174/1874613601004020054 Text en © Liu and Lu; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Liu, Li
Lu, Hongzhou
Technology Development Through Pooling ARV Drug Patents: A Vision from China
title Technology Development Through Pooling ARV Drug Patents: A Vision from China
title_full Technology Development Through Pooling ARV Drug Patents: A Vision from China
title_fullStr Technology Development Through Pooling ARV Drug Patents: A Vision from China
title_full_unstemmed Technology Development Through Pooling ARV Drug Patents: A Vision from China
title_short Technology Development Through Pooling ARV Drug Patents: A Vision from China
title_sort technology development through pooling arv drug patents: a vision from china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831193/
https://www.ncbi.nlm.nih.gov/pubmed/20224635
http://dx.doi.org/10.2174/1874613601004020054
work_keys_str_mv AT liuli technologydevelopmentthroughpoolingarvdrugpatentsavisionfromchina
AT luhongzhou technologydevelopmentthroughpoolingarvdrugpatentsavisionfromchina